Glossary of medical terms: A B C D E F G H I J K L M N O P Q R S T U W V Y Z
Home » Medical Dictionary
 

  Vaccination, hepatitis B

Medical Dictionary

Hepatitis B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required.
All infants in the U.S. receive hep B vaccine. Two vaccines (Engerix-B, and Recombivax-HB) are available in the US. The first dose of hep B vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later.

Babies born to mothers testing positive for hep B receive, in addition, HBIG (hep B immune globulin) for prompt protection.

Older children (11-12 years) are advised to receive a hep B booster.

Adults in high-risk situations are also advised to get a hep A booster. Those in high-risk situations include healthcare workers, dentists, intimate and household contacts of patients with chronic hep B infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, IV drug users, and recipients of repeated transfusions. Healthcare workers accidentally exposed to materials infected with hep B (such as needle sticks), and individuals with known sexual contact with hep B patients are available in the U.S.

Both vaccines (Engerix-B, and Recombivax-HB) are highly effective and provide protection even after only one dose. However, as indicated, two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection.

Latest Medical News

» U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
» Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
» FDA approves Inlyta to treat patients with a type of advanced kidney cancer
» FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
» FDA. New and Generic Drug Approvals - January 27, 2012
» FDA. New and Generic Drug Approvals - January 26, 2012
» FDA. New and Generic Drug Approvals - January 25, 2012

Latest Medical Articles

» Wrist Injuries and Disorders
» West Nile Virus
» Wegener`s Granulomatosis
» Vulvar Disorders
» Vulvar Cancer
» Vitiligo
» Von Hippel-Lindau Disease
 

Latest Drugs

» Efavirenz Teva
» Desloratadine Actavis
» Repaglinide Accord
» Emselex
» Hepsera
» Zulvac 1 Ovis
» Zulvac 1 Bovis
 

Random terms - Medical Dictionary

Babesiosis, HPC, Hgb, Dermatosclerosis, Dietary Supplements, Efferent Pupillary Defects, Electrooculogram, Enalaprilat, (R)-Isomer, Anhydrous, Eserine, Ethics, Situational, Health Aide, Home, HTLV-IV, Infection, Equine Strongyle, Intermediate Maple Syrup Urine Disease, Ladder, Job, Legal Right, Levorine, Ligaments, Longitudinal, Malignant Hyperthermia, Markers, Biochemical, Neck Neoplasms, Neoplastic Transformations, Cell, Neurological Manifestation, Osmoregulations, Proto-Oncogene Products c-mos, Puff, Calcium, Benign Optic Nerve Tumor, Blastocyte, ras-Related rap Proteins, Receptor, Neuromediator, Recombinant Interferon Alfa-2b, Repetitive Sequences, Amino Acid, Ring Chromosomes, Sectionings, Thin, Smoke Inhalation Injuries, Sociopathic Personality, Statistical Factor Analyses, Sun Glasses, Prescription, Syndrome, Multiple Hamartoma, Test, Passive Transfer,

General Search


Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap